Observational retrospective study of the treatment of Waldenström's macroglobulinemia with ibrutinib in routine clinical practice in Spain.

Ther Adv Hematol · 2025 · PMC12501444 · PMID 41064016

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, age (66–75 years and >75 years) and LDH levels ⩾250 U/L, showed a trend toward poorer PFS outcomes ( Supplemental Table 1 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.